Clinique de Genolier

Dr. med. Michael Montemurro

Spécialiste FMH en Hématologie

Spécialiste FMH en Médecine Interne

Spécialiste en Médecine interne, Hématologie et Oncologie médicale 

Sprachen
EN DE FR IT

Kontakt

Klinik (1)

Clinique de Genolier
Route du Muids 3
1272 Genolier

Berufserfahrung

seit 2021

Consultant, Oncologie médicale, University College London Hospitals, UK

2020

Médecin Chef, Oncologie médicale, EHC Morges Hospital, CH

2016 - 2020
Médecin Adjoint, Oncologie médicale, CHUV Lausanne, CH
2014 - 2015

Médecin Associé, Oncologie médicale, IOSI-EOC, Ospedale Bellinzona, CH

2013 - 2014
Sarcoma Unit, The Royal Marsden Hospital London, UK
2012

Oncologie médicale, CHU Zürich, CH

2005 - 2012

Centre Pluridisciplinaire d’Oncologie (CePO), CHUV Lausanne, CH

Kompetenzen

  • Tumeurs digestives : colon, rectum, foie, pancréas, estomac, oesophage, neruo-endocrine) 
  • GIST (tumeur gastrointestinale stromale) 
  • Sarcomes des tissus mous et osseux 

Publikationen

Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.
Montemurro, M. et al. 2021 Feb;27(2):289-300

Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma. Dunet V, Halkic N, Sempoux C, Demartines N, Montemurro M, Prior JO, Schmidt S.; Eur Radiol. 2021 Feb;31(2):992-1001

LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma
Montemurro, M., et al. Cell Rep. 2020 Mar 31;30(13):4567-4583

Oncological outcome, functional results and costs after unplanned excision of musculoskeletal soft tissue sarcoma
Morattel , Mustaki, Montemurro, Letovanec, Durham, Becce, Omoumi, di Summa, Matter, Rüdiger , Cherix
Eur J Surg Oncol. 2020 May;46(5):898-904

Tumor response and outcome after reverse treatment for patients with synchronous colorectal liver metastasis ….
Du Pasquier C, Roulin D, Bize P, Sempoux C, Rebecchini C, Montemurro M, Schäfer M, Halkic N, Demartines N.
BMC Surg. 2020 Apr 19;20(1):78

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer. 
De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M. J Cancer Res Clin Oncol. 2019 Apr;145(4):1075-1084

Long-term outcome of dasatinib first-line treatment in GIST: A multicenter, 2-stage phase 2 trial (SAKK 56/07).
Montemurro M et al.; Cancer. 2018 Apr 1;124(7):1449-1454

Sarcoma of the heart: survival after surgery.
Niclauss L, Montemurro M, Kirsch M, Prêtre R.; Interact Cardiovasc Thorac Surg. 2018 Aug; 27(2):198-201

Radiation Therapy for GIST Progressing During Or After Tyrosine Kinase Inhibitor Therapy: A Prospective Study
Joensuu H, Eriksson M, Collan J, Balk M, Leyvraz S, Montemurro M; Radiother Oncol. 2015 Aug; 116(2):233-8

Survival after surgical drainage of malignant pericardial effusion
Niclauss L, Montemurro M, Prêtre R; World J Surg 2015 Jul;39(7):1767

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour …..
M. Montemurro et al.; European Journal of Cancer 2013 Mar;49(5):1027-31

Continuous Sunitinib treatment in patients with advanced HCC: a SAKK and SASL multicenter phase II trial (SAKK 77/06). Koeberle D, Montemurro M et al.; Oncologist. 2010;15(3):285-92.

Early prediction of response to sunitinib after imatinib failure by 18F-FDG-PET in patients with GIST
Prior JO, Montemurro M et al. ; J Clin Oncol. 2009 Jan 20;27(3):439-45. Epub 2008 Dec 8.
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Montemurro M et al.; Eur J Cancer. 2009 Sep;45(13):2293-7

PCNSL treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell
transplantation and response-adapted whole-brain radiotherapy: results of the multicenter OSHO-53 phase II study. Montemurro M et al.; Ann Oncol. 2007 Apr;18(4):665-71.

Chapitre de Livre

Principles of Tumor Therapy
In: “HEROLD – INNERE MEDIZIN”, Gerd Herold (editeur), Germany; since 2010, mis à jour annuelle

Ausbildung

2019
ESMO Examination Oncologie médicale
2003

Hématologie et Oncologie interne

2002

Médecine interne

1999
Thèse de recherche, Faculté de médecine, Université Essen, Allemagne
1989 - 1995

Médecine, Johann Wolfgang Goethe Universität, Frankfurt, Allemagne

Mitgliedschaften

Awards

  • 2018 : Prix annuel du Groupe GIST Group Suisse
  • 2012 : Prix annuel du Groupe GIST Group Suisse
  • 2011 : Prix d'honneur du Groupe GIST Group Suisse pour "Living with GIST"
  • 2011 : Edi 2011 (argent): Film documentaire "Living with GIST
  • 2011 : Membre d’honneur du groupe GIST Suisse (www.gist.ch)
  • 2010 : Prix annuel du Groupe GIST Group Suisse

Ärzte mit dieser Spezialisierung

Clinica Sant'Anna

Dr. med. Florenc Kola

Spezialisierung
Geriatrie (Altersmedizin), Innere Medizin
Ladies Permanence Stadelhofen

Dr. med. Ursula Nadig-Glaser

Spezialisierung
Gynäkologie, Innere Medizin, Geburtshilfe
Privatklinik Bethanien

Dr. med. Claudia Tüller

Spezialisierung
Pneumologie, Innere Medizin
Clinique de Genolier

Dr. med. Lucia Quadri

Spezialisierung
Innere Medizin
fallback-image
Clinica Sant'Anna

Dr. med. Michail Kouros

Spezialisierung
Innere Medizin, Krebstherapien und Onkologie
Ärzteteam Seewadel

Dr. med. Petia Will

Spezialisierung
Allgemeine Medizin, Innere Medizin, Akupunktur